Number of Shares
823.00
Current Holdings Value*
$41,310.00
% of Portfolio
2.09%
Total Estimate Gain
$5,673.85
% of Total Estimate Gain
6.31%

Disciplined U.S. Value Equity Portfolio's Bristol-Myers Squibb Co Holding Summary

As of 2025-04-30, Disciplined U.S. Value Equity Portfolio held 823.00 shares of Bristol-Myers Squibb Co(BMY), totaling $41,310.00. This investment constitutes 2.09% of their stock portfolio, and Disciplined U.S. Value Equity Portfolio now holds 0% of the outstanding Bristol-Myers Squibb Co(BMY) stock.

The initial trade took place in 2019Q4. And since then Disciplined U.S. Value Equity Portfolio has made 4 purchases of BMY, at an average price of $51.96, for a total of 1,731.00 shares. In addition, there have been 3 sales at an average price of $62.67 for 908.00 shares. Based on historical transaction data and BMY's current price of $47.04, Disciplined U.S. Value Equity Portfolio's estimated gain on his BMY holdings is $5,673.85, reflecting a 6.31% gain to date.

Disciplined U.S. Value Equity Portfolio BMY ($47.04) Holding Chart

Disciplined U.S. Value Equity Portfolio BMY ($47.04) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1